Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 43 min ago
Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer

902 Reprogrammed regulatory T cells as cytotoxic effectors drive anti-tumor immunity under bispecific T cell engager therapy

  • Carsten Müller-Tidow1
  • Hartmut Goldschmidt2
  • Hermann Einsele3
  • Niklas Kehl4
  • Julius Michel5
  • Alexander Brobeil6
  • Niels Weinhold7
  • Leo Rasche8
  • Marta Chesi9
  • Peter Leif Bergsagel10
  • Jan H Frenking7
  • Anna Metzler7
7 more authors
  • Erin W Meermeier11
  • Antonia Schach7
  • Vera Thiel12
  • Tim Wagner7
  • Stefanie Huhn7
  • Marc Raab7
  • Mirco Friedrich7
12 affiliations
  1. 12 Molecular Medicine Partnership Unit (MMPU), Heidelberg, Heidelberg, Baden-Württemberg, Germany
  2. 2Department of Medicine V, University Hospital and Medical Faculty Heidelberg, Heidelberg, Baden-Württemberg, Germany
  3. 3Bavarian Center for Cancer Research (BZKF), Würzburg, Germany
  4. 4German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Baden Württemberg, Germany
  5. 52Mannheim Center for Translation Neuroscience (MCTN), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
  6. 66 Department of Pathology, University Hospital Heidelberg, Heidelberg, Germany
  7. 7Heidelberg Myeloma Center, Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Baden Württemberg, Germany
  8. 8Department of Internal Medicine II, University Hospital Wurzburg, Wurzburg, Germany
  9. 98Mayo Clinic, Scottsdale, AZ, USA
  10. 10Mayo Clinic, Scottsdale, AZ, USA
  11. 11Mayo Clinic Arizona, Department of Medicine, Division of Hematology/Oncology, Scottsdale, AZ, USA
  12. 12Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Baden Württemberg, Germany
Open at sourcePDFDOICite

Related

  1. Grapevine rust fungus Neophysopella tropicalis deploys protein effectors with plant immunity-suppressing activity during sequential stages of pathogenesis.
    Thiago Maia, João Vitor Ferro, Gustavo Husein +2
    Plant cell reportsPeer-reviewedCC BYFull textPlant biologyEurope PMC
  2. Cytotoxic T-cell lymphoma with muscle involvement and germline variants in inborn error of immunity-related genes: clinical and genetic insights from a case series
    Chong Wei, Danqing Zhao, Congwei Jia +3
    HaematologicaPeer-reviewedCC BY-NC 4.0Full textImmunologyPMC
  3. Bridging innate and adaptive immunity: A bispecific SIRPαD1-αPCSK9 fusion protein reprograms macrophages for durable tumor clearance
    Caili Xu, Kaicheng Zhou, Xiaozhi Hu +10
    Cell Reports MedicinePeer-reviewedCC BY-NC-ND 4.0Full textImmunologyPMC
  4. Weaning imprints a hybrid cytotoxic-regulatory identity on intestinal CD4+ T lymphocytes
    Marina Schernthanner, Rohit R. Gokhale, Alexandra Thoms +11
    bioRxivPreprintCC BYFull textImmunologybioRxivPMC
  5. Pimozide enhances antigen cross-presentation and promotes cytotoxic CD8+ T cell immunity by stimulating dendritic cells
    Luz María Palacios, Nicolás Daniel Dho, Cintia Liliana Araujo Furlán +9
    Frontiers in immunologyPeer-reviewedCC BYFull textImmunologyEurope PMCCrossref

Cite

BibTeXRIS
BibTeX
@article{mullertidow2026reprogrammed,
  title = {{902 Reprogrammed regulatory T cells as cytotoxic effectors drive anti-tumor immunity under bispecific T cell engager therapy}},
  author = {Carsten Müller-Tidow and Hartmut Goldschmidt and Hermann Einsele and Niklas Kehl and Julius Michel and Alexander Brobeil and Niels Weinhold and Leo Rasche and Marta Chesi and Peter Leif Bergsagel and Jan H Frenking and Anna Metzler and Erin W Meermeier and Antonia Schach and Vera Thiel and Tim Wagner and Stefanie Huhn and Marc Raab and Mirco Friedrich},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  month = nov,
  doi = {10.1136/jitc-2026-sitc2026.0902},
  url = {https://doi.org/10.1136/jitc-2026-sitc2026.0902},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - 902 Reprogrammed regulatory T cells as cytotoxic effectors drive anti-tumor immunity under bispecific T cell engager therapy
AU  - Carsten Müller-Tidow
AU  - Hartmut Goldschmidt
AU  - Hermann Einsele
AU  - Niklas Kehl
AU  - Julius Michel
AU  - Alexander Brobeil
AU  - Niels Weinhold
AU  - Leo Rasche
AU  - Marta Chesi
AU  - Peter Leif Bergsagel
AU  - Jan H Frenking
AU  - Anna Metzler
AU  - Erin W Meermeier
AU  - Antonia Schach
AU  - Vera Thiel
AU  - Tim Wagner
AU  - Stefanie Huhn
AU  - Marc Raab
AU  - Mirco Friedrich
PY  - 2026
DA  - 2026/11/06
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2026-sitc2026.0902
UR  - https://doi.org/10.1136/jitc-2026-sitc2026.0902
SN  - 2051-1426
ER  -